Breaking News Instant updates and real-time market news.

CTST

CannTrust

$5.90

0.3 (5.36%)

, AMRS

Amyris

$4.54

-0.02 (-0.44%)

08:45
05/13/19
05/13
08:45
05/13/19
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: CannTrust Holdings (CTST) 35.52% +1.42, Amyris (AMRS) 36.57% +0.53, (BYND) 24.23% +0.46, Alerian (AMLP) 2.01% +0.07, Banco Santander (SAN) 6.55% +0.06, ProShares UltraPro Short S&P 500 (SPXU) 3.18% +0.05, ProShares UltraShort QQQ (QID) 4.92% +0.03, ING Group (ING) 0.28% +0.01, Widsomtree Japan (DXJ) 0.82% +0.01, and FirstEnergy (FE) 0.38% +0.01.

CTST

CannTrust

$5.90

0.3 (5.36%)

AMRS

Amyris

$4.54

-0.02 (-0.44%)

BYND

Beyond Meat

$66.22

-2.08 (-3.05%)

SAN

Banco Santander

$4.67

0.025 (0.54%)

QID

ProShares UltraShort QQQ

$32.57

-0.05 (-0.15%)

ING

ING Group

$11.88

0.05 (0.42%)

DXJ

WisdomTree Japan Hedged Equity Fund

$49.42

0.365 (0.74%)

FE

FirstEnergy

$42.14

0.755 (1.82%)

  • 14

    May

  • 21

    May

  • 06

    Jun

CTST CannTrust
$5.90

0.3 (5.36%)

AMRS Amyris
$4.54

-0.02 (-0.44%)

11/14/18
HCWC
11/14/18
NO CHANGE
Target $11
HCWC
Buy
Amyris price target lowered to $11 from $15 at H.C. Wainwright
H.C. Wainwright analyst Amit Dayal lowered his price target for Amyris to $11 to reflect a more conservative stance on forward projections, including removing around $40M of anticipated annual Vitamin E royalty revenues, following the company's revenue miss in Q3. The analyst, however, keeps a Buy rating on the shares.
02/05/19
HCWC
02/05/19
NO CHANGE
Target $11
HCWC
Buy
H.C. Wainwright reiterates $11 target on Amyris after $255M cannabinoid deal
Amyris this morning announced a $255M collaboration agreement, its largest yet, with an unnamed partner, for cannabinoid development and licensing, H.C. Wainwright analyst Amit Dayal tells investors in a research note. The analyst reiterates a Buy rating on the shares with an $11 price target. The stock in morning trading is up 42%, or $1.33, to $4.49. Dayal believes the agreement calls for several molecules that will be targeting multiple products and end markets, with the first commercial production taking place in 18-24 months. He thinks the early applications are targeting opportunities in the skin care and beverage markets. Further, with an executed binding term sheet in place leading to the announcement, Dayal sees a "high probability" of the deal closing within the expected timeline. And since the non-psychoactive cannabidiol based molecules developed using Amyris' fermentation technology are likely to bypass the psychoactive tetrahydrocannabinol molecule pathway, the regulatory approval process "should not run afoul of the federal THC related restrictions," the analyst writes. He views today's announcement as an "important signal about the scalability" of Amyris' technology platform to enter large new markets very quickly. The analyst also believes the development timeline is "realistic given that product development has been accelerating at the company."
12/31/18
HCWC
12/31/18
NO CHANGE
Target $11
HCWC
Buy
Amyris news today a 'significant near-term milestone,' says H.C. Wainwright
H.C. Wainwright analyst Amit Dayal maintains a Buy rating on Amyris with an $11 price target after the company entered into a long-term agreement with Xinfu for an upfront payment of $50M and an additional long-term annual share upside based on an existing nutritional product royalty arrangement. Amyris is capitalizing on its relationship with Xinfu to monetize a portion of the long-term royalty opportunity upfront, which should lower quarterly volatility from this "high-margin" revenue stream while continuing to benefit from future royalty payments, Dayal tells investors in a research note. He thinks today's news should be viewed as a "timely delivery of a significant near-term milestone by the management team."
12/07/18
HCWC
12/07/18
NO CHANGE
HCWC
Amyris financing removes 'important overhang,' says H.C. Wainwright
H.C. Wainwright analyst Amit Dayal reiterated a Buy rating and $11 price target on Amyris, noting that the company announced it has entered into definitive agreements for the sale of $60M of unsecured convertible senior notes, in a private placement with two investors. Dayal said this financing removes an "important overhang" for the company, and believes that Amyris is now positioned to focus on execution during 2019. The analyst added that he is looking forward to more information from the company during the last three weeks of this year, including the announcement of a Chinese licensing agreement.
BYND Beyond Meat
$66.22

-2.08 (-3.05%)

05/03/19
BMOC
05/03/19
UPGRADE
BMOC
Outperform
Maple Leaf Foods upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Peter Sklar upgraded Maple Leaf Foods (MLFNF) to Outperform from Market Perform and raised his price target for the shares to C$39 from C$31. Following the initial public offering of Beyond Meat (BYND), the analyst believes investors could "readily attribute" a valuation of at least $1B to Maple Leaf's plant-based businesses. As such, he sees potential valuation upside from current share levels.
05/06/19
BERN
05/06/19
INITIATION
BERN
Outperform
Beyond Meat initiated with an Outperform at Bernstein
SAN Banco Santander
$4.67

0.025 (0.54%)

06/14/18
HSBC
06/14/18
UPGRADE
HSBC
Buy
Banco Santander upgraded to Buy from Hold at HSBC
03/13/19
MSCO
03/13/19
UPGRADE
MSCO
Overweight
Banco Santander upgraded to Overweight from Equal Weight at Morgan Stanley
02/08/19
GSCO
02/08/19
UPGRADE
GSCO
Conviction Buy
Banco Santander upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Jose Abad said that following an "unprecedented value reversal" in the last year and a half, his sum-of-the-parts analysis of Banco Santander's value is 140% of the group's market cap. Using his SOTP value, the stock trades at a 28% discount, or its greatest such discount in 10 years, said Abad, who added the stock to the firm's Conviction List with a Buy rating. He also raised his price target on Banco Santander shares to EUR6.18 from EUR5.96.
10/02/18
KBWI
10/02/18
DOWNGRADE
KBWI
Market Perform
Banco Santander downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Daragh Quinn downgraded Banco Santander to Market Perform and lowered his price target for the shares to EUR 5.10 from EUR 6. The analyst expects the stock to be a relative underperformer given uncertainty from the political situations in Brazil and Europe.
QID ProShares UltraShort QQQ
$32.57

-0.05 (-0.15%)

ING ING Group
$11.88

0.05 (0.42%)

01/15/19
FBCO
01/15/19
UPGRADE
FBCO
Neutral
ING Group upgraded to Neutral from Underperform at Credit Suisse
01/16/19
SOCG
01/16/19
UPGRADE
SOCG
Buy
ING Group upgraded to Buy from Hold at Societe Generale
Societe Generale analyst Phelbe Pace upgraded ING Group to Buy with a price target of EUR 13.50.
01/16/19
01/16/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MetLife (MET) upgraded to Buy from Neutral at BofA/Merrill with analyst Jay Cohen saying quality concerns are diminishing as management addresses past issues and believes the business mix has notably changed for the positive following the Brighthouse spin. 2. ING Group (ING) upgraded to Buy from Hold at Societe Generale. 3. Williams (WMB) upgraded to Overweight from Equal Weight at Barclays analyst Christine Cho saying the company is now positioned to reduce leverage at an accelerated pace and internally fund incremental growth projects and/or return capital to shareholders in a more meaningful way. 4. Accenture (ACN) upgraded to Buy from Neutral at Citi with analyst Ashwin Shirvaikar saying against a backdrop of rising political and policy risks, a more defensive Information Technology Services stance is appropriate. 5. Nutanix (NTNX) and Teradata (TDC) were upgraded to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/21/19
RBCM
03/21/19
UPGRADE
RBCM
Outperform
ING Group upgraded to Outperform from Sector Perform at RBC Capital
DXJ WisdomTree Japan Hedged Equity Fund
$49.42

0.365 (0.74%)

FE FirstEnergy
$42.14

0.755 (1.82%)

03/05/19
MSCO
03/05/19
NO CHANGE
MSCO
Morgan Stanley downgrades Energy sector to Equal Weight from Overweight
Morgan Stanley equity strategist Michael Wilson said the firm's strategy team expects further declines in earnings forecasts for the Energy sector and are moving to Equal Weight from Overweight on the sector while they remain overweight Utilities. The firm's Energy and Utilities analysts highlight Baker Hughes (BHGE), Bloom Energy (BE), BP (BP), ConocoPhillips (COP), FirstEnergy (FE), Marathon Petroleum (MPC), Suncor (SU), TechnipFMC (FTI) and Tenaris (TS) as their top picks.
03/20/19
LEHM
03/20/19
NO CHANGE
LEHM
Barclays upgrades NextEra and FirstEnergy, downgrades NorthWestern
Barclays analyst Eric Beaumont upgraded both NextEra Energy (NEE) and FirstEnergy (FE) to Overweight from Equal Weight while downgrading NorthWestern (NWE) to Underweight from Equal Weight. The rating changes reflect the analyst's updated valuations based on 2021 estimates combined with price performance over the past quarter. On NextEra, he believes "top industry growth" combined with an above-average regulatory environment will drive the valuation. FirstEnergy currently looks like a "deep value or show-me story," but with a transformative 2018 behind it, execution on the story in 2019 will be the key driver to stock performance, Beaumont tells investors in a research note. For NorthWestern, the analyst thinks the stock is discounting too optimistic of an outcome for the Montana rate case.
04/05/19
BOFA
04/05/19
NO CHANGE
Target $48
BOFA
Buy
FirstEnergy a Buy at most compelling valuation in a year, says BofA/Merrill
BofA/Merrill analyst Julien Dumoulin-Smith kept his Buy rating and $48 price target on FirstEnergy, saying yesterday's 4% decline in the stock price driven by the rejection of its $4B restructuring plan by a bankruptcy court has taken its valuation to the "most compelling" level in the past year. The analyst notes that in spite of the concerns about additional environmental liabilities translating back to FirstEnergy, the regulators are lacking datapoints to identify further liabilities, adding that the company has also already allocated about $200M in a surety bond to address further concerns.
03/20/19
LEHM
03/20/19
UPGRADE
Target $46
LEHM
Overweight
FirstEnergy upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Eric Beaumont upgraded FirstEnergy to Overweight from Equal Weight and raised his price target for the shares to $46 from $40.

TODAY'S FREE FLY STORIES

RVLT

Revolution Lighting

$0.34

-0.0124 (-3.57%)

18:10
08/22/19
08/22
18:10
08/22/19
18:10
Hot Stocks
Revolution Lighting discloses additional delisting determination from Nasdaq »

Revolution Lighting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

Iberiabank

$70.16

-0.38 (-0.54%)

18:05
08/22/19
08/22
18:05
08/22/19
18:05
Hot Stocks
Iberiabank CEO Daryl Byrd sells over $840K in company shares »

Iberiabank CEO Daryl Byrd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

RMNI

Rimini Street

$4.77

-0.11 (-2.25%)

, ORCL

Oracle

$53.18

-0.08 (-0.15%)

18:02
08/22/19
08/22
18:02
08/22/19
18:02
Hot Stocks
San Fang Chemical switches to Rimini Street support for Oracle EBS »

Rimini Street (RMNI)…

RMNI

Rimini Street

$4.77

-0.11 (-2.25%)

ORCL

Oracle

$53.18

-0.08 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$148.26

0.86 (0.58%)

18:01
08/22/19
08/22
18:01
08/22/19
18:01
Hot Stocks
Salesforce says Customer 360 will be huge growth driver over next decade »

Says: Momentum in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

AAC

AAC Holdings

$0.60

-0.0327 (-5.17%)

17:57
08/22/19
08/22
17:57
08/22/19
17:57
Hot Stocks
AAC Holdings discloses NYSE listing notice »

AAC Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

17:32
08/22/19
08/22
17:32
08/22/19
17:32
General news
Fed Balance Sheet Level data reported »

Week of 8/21 Fed Balance…

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

17:30
08/22/19
08/22
17:30
08/22/19
17:30
Hot Stocks
HP Inc. says notebooks accounted for 39% of revenue in Q3 »

Says supplies category…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

17:28
08/22/19
08/22
17:28
08/22/19
17:28
General news
Money Supply M2 Weekly Change data reported »

Week of 8/12 Money Supply…

TRPX

Therapix Biosciences

$2.35

(0.00%)

17:27
08/22/19
08/22
17:27
08/22/19
17:27
Syndicate
Breaking Syndicate news story on Therapix Biosciences »

Therapix Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$141.38

-0.36 (-0.25%)

17:26
08/22/19
08/22
17:26
08/22/19
17:26
Hot Stocks
SPDR Gold Shares holdings rise to 854.84MT to 851.91MT »

This is the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

17:19
08/22/19
08/22
17:19
08/22/19
17:19
Earnings
VMware sees Q3 adjusted EPS $1.42, consensus $1.57 »

Sees Q3 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

  • 10

    Oct

CRWD

Crowdstrike

$93.04

-3.5 (-3.63%)

, CBLK

Carbon Black

$24.52

1.77 (7.78%)

17:14
08/22/19
08/22
17:14
08/22/19
17:14
Hot Stocks
Crowdstrike lower after Carbon Black acquisition »

Shares of cybersecurity…

CRWD

Crowdstrike

$93.04

-3.5 (-3.63%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

17:07
08/22/19
08/22
17:07
08/22/19
17:07
Hot Stocks
HP Inc. says CEO Dion Weisler will step down to deal with family health matter »

Says Enrique Lores, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

NP

Neenah Paper

$66.14

-0.455 (-0.68%)

17:05
08/22/19
08/22
17:05
08/22/19
17:05
Hot Stocks
Neenah Paper CFO sells 7.8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

17:04
08/22/19
08/22
17:04
08/22/19
17:04
Hot Stocks
HP Inc. falls over 5% amid slowdown in printer sales »

Shares of HP Inc. are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

NKE

Nike

$83.27

0.46 (0.56%)

17:03
08/22/19
08/22
17:03
08/22/19
17:03
Periodicals
Michael Avenatti plans subpoenas to prove Nike claims, Bloomberg says »

Attorney Michael Avenatti…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

17:00
08/22/19
08/22
17:00
08/22/19
17:00
Hot Stocks
HP Inc. printing net revenue was down 5% year over year »

Printing net revenue was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

SYY

Sysco

$73.32

1.06 (1.47%)

16:56
08/22/19
08/22
16:56
08/22/19
16:56
Hot Stocks
Sysco director Koerber sells 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 25

    Sep

  • 01

    Oct

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

, CBLK

Carbon Black

$24.52

1.77 (7.78%)

16:54
08/22/19
08/22
16:54
08/22/19
16:54
Earnings
VMware raises FY20 EPS view to $6.54 from $6.49, consensus $6.52 »

Sees Carbon Black (CBLK)…

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

VMW

VMware

$148.15

0.11 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

AFH

Atlas Financial

$0.41

-0.0323 (-7.29%)

16:53
08/22/19
08/22
16:53
08/22/19
16:53
Hot Stocks
Atlas Financial gives update on ongoing strategic review »

Atlas Financial Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEN

Zendesk

$80.87

0.57 (0.71%)

16:51
08/22/19
08/22
16:51
08/22/19
16:51
Hot Stocks
Zendesk CEO sells 100K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 09

    Sep

  • 10

    Sep

  • 10

    Sep

  • 13

    Nov

CBLK

Carbon Black

$24.52

1.77 (7.78%)

16:50
08/22/19
08/22
16:50
08/22/19
16:50
Hot Stocks
Breaking Hot Stocks news story on Carbon Black »

Carbon Black trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRS

Amyris

$4.07

-0.25 (-5.79%)

16:45
08/22/19
08/22
16:45
08/22/19
16:45
Hot Stocks
Amyris receives deficiency notification from Nasdaq »

Amyris reported that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

DDS

Dillard's

$56.36

-0.21 (-0.37%)

16:43
08/22/19
08/22
16:43
08/22/19
16:43
Hot Stocks
Dillard's increases quarterly dividend 50% »

Dillard's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAS

Hasbro

$114.35

-1.06 (-0.92%)

16:43
08/22/19
08/22
16:43
08/22/19
16:43
Hot Stocks
Hasbro to acquire Entertainment One in all-cash deal valued at about $4B »

Hasbro and Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.